SectorBiological Technology
Established Date02/04/1998
Listing Date01/06/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees29
Fiscal Year Ends31/12
Security TypeCommon stock
Office address4350 Executive Drive
Suite 325
San Diego
California 92121
Business
IntroductionOncolytics Biotech Inc., was incorporated under the laws of Alberta on April 2, 1998 as an Alberta limited liability company, and was re-incorporated in Nevada on April 1, 2026. The company is a clinical-stage biopharmaceutical company developing pelareorep, an intravenously administered immunotherapy drug designed to selectively replicate and activate immune responses in RAS-mutated tumors. The company is not yet profitable and needs additional financing to stay afloat.
